Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Un-Audited Standalone & Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has informed BSE that its Board of Directors will meet on Tuesday, August 12, 2025, at the registered office. The main agenda is to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2025. The trading window for directors, promoters, designated employees, and specified connected persons remains closed till August 14, 2025, in line with insider trading norms. This is a standard regulatory intimation under SEBI Listing Regulations. No actual financial numbers have been disclosed yet; they will be released after the board meeting.
Routine procedural filing with no immediate impact on shareholders. Investors should watch for the actual Q1 results on August 12, 2025, which could move the stock depending on performance versus expectations.